- Home
- BZH vs VALN Comparison
BZH vs VALN Comparison
Compare BZH & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZH
- VALN
- Stock Information
- Founded
- BZH 1985
- VALN 2012
- Country
- BZH United States
- VALN France
- Employees
- BZH N/A
- VALN N/A
- Industry
- BZH Homebuilding
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BZH Consumer Discretionary
- VALN Health Care
- Exchange
- BZH Nasdaq
- VALN Nasdaq
- Market Cap
- BZH 591.6M
- VALN 510.7M
- IPO Year
- BZH 1994
- VALN 2021
- Fundamental
- Price
- BZH $20.53
- VALN $6.40
- Analyst Decision
- BZH Strong Buy
- VALN Strong Buy
- Analyst Count
- BZH 3
- VALN 3
- Target Price
- BZH $37.00
- VALN $15.33
- AVG Volume (30 Days)
- BZH 409.9K
- VALN 83.3K
- Earning Date
- BZH 05-01-2025
- VALN 05-07-2025
- Dividend Yield
- BZH N/A
- VALN N/A
- EPS Growth
- BZH N/A
- VALN N/A
- EPS
- BZH 3.10
- VALN N/A
- Revenue
- BZH $2,436,131,000.00
- VALN $201,099,222.00
- Revenue This Year
- BZH N/A
- VALN $18.74
- Revenue Next Year
- BZH $14.27
- VALN $29.26
- P/E Ratio
- BZH $6.61
- VALN N/A
- Revenue Growth
- BZH 13.50
- VALN 21.64
- 52 Week Low
- BZH $17.37
- VALN $3.62
- 52 Week High
- BZH $38.22
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- BZH 46.74
- VALN 48.49
- Support Level
- BZH $20.20
- VALN $6.18
- Resistance Level
- BZH $21.42
- VALN $6.54
- Average True Range (ATR)
- BZH 0.78
- VALN 0.21
- MACD
- BZH -0.19
- VALN 0.01
- Stochastic Oscillator
- BZH 8.76
- VALN 54.35
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.